1,479 results on '"Montine, Thomas J"'
Search Results
2. Neuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohorts
3. Single-cell peripheral immunoprofiling of Lewy body and Parkinson’s disease in a multi-site cohort
4. Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson’s disease
5. Paradigm Shift: Multiple Potential Pathways to Neurodegenerative Dementia
6. A visual–language foundation model for pathology image analysis using medical Twitter
7. Characterization of hippocampal sclerosis of aging and its association with other neuropathologic changes and cognitive deficits in the oldest-old
8. Mediterranean diet protects against a neuroinflammatory cortical transcriptome: Associations with brain volumetrics, peripheral inflammation, social isolation, and anxiety in nonhuman primates (Macaca fascicularis)
9. Quantitative estimate of cognitive resilience and its medical and genetic associations
10. Cross-species comparative analysis of single presynapses
11. Whole genome deconvolution unveils Alzheimer’s resilient epigenetic signature
12. A peptide-centric quantitative proteomics dataset for the phenotypic assessment of Alzheimer’s disease
13. Brain proteomic analysis implicates actin filament processes and injury response in resilience to Alzheimer’s disease
14. Clonal hematopoiesis is associated with protection from Alzheimer’s disease
15. Rapid Deployment of Whole Slide Imaging for Primary Diagnosis in Surgical Pathology at Stanford Medicine: Responding to Challenges of the COVID-19 Pandemic
16. LATE-NC staging in routine neuropathologic diagnosis: an update
17. Gait and balance in apolipoprotein Ɛ4 allele carriers in older adults and Parkinson’s disease
18. Frequency of LATE neuropathologic change across the spectrum of Alzheimer’s disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts
19. Discovery of azaspirocyclic 1H-3,4,5-Trisubstitued pyrazoles as novel G2019S-LRRK2 selective kinase inhibitors
20. Methylation differences in Alzheimer’s disease neuropathologic change in the aged human brain
21. Cognition as a mediator for gait and balance impairments in GBA-related Parkinson’s disease
22. Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer’s disease
23. Single-cell spatial proteomic imaging for human neuropathology
24. Discovery of G2019S-Selective Leucine Rich Repeat Protein Kinase 2 inhibitors with in vivo efficacy
25. Plasma pTau181 Reveals a Pathological Signature that Predicts Cognitive Outcomes in Lewy Body Disease.
26. Genome-wide association study and functional validation implicates JADE1 in tauopathy
27. Alzheimer’s Disease Neuropathologic Change and Vitamin Supplement Use Decades Earlier: The 90+ Study
28. The Parkinson's Disease Composite of Executive Functioning: A Measure for Detecting Cognitive Decline in Clinical Trials.
29. Neuropathologic changes at age 90+ related to sleep duration 19 to 40 years earlier: The 90+ Study.
30. Multiple biomarkers improve diagnostic accuracy across Lewy body and Alzheimer's disease spectra.
31. Arterial spin labeling detects perfusion patterns related to motor symptoms in Parkinson's disease
32. Single-cell epigenomic analyses implicate candidate causal variants at inherited risk loci for Alzheimer’s and Parkinson’s diseases
33. Enantiomers of 2-methylglutamate and 2-methylglutamine selectively impact mouse brain metabolism and behavior
34. Cognitive associations with comprehensive gait and static balance measures in Parkinson's disease
35. Large-scale proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation
36. The basis of cellular and regional vulnerability in Alzheimer’s disease
37. Prediction of cognitive progression in Parkinson's disease using three cognitive screening measures
38. A nonhuman primate model of early Alzheimer's disease pathologic change: Implications for disease pathogenesis
39. Lewy body dementia: Overcoming barriers and identifying solutions.
40. Sex differences in progression to mild cognitive impairment and dementia in Parkinson's disease
41. The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable
42. Sex-specific genetic predictors of Alzheimer’s disease biomarkers
43. Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study
44. Engineering monocyte/macrophage−specific glucocerebrosidase expression in human hematopoietic stem cells using genome editing
45. Impact of a deep learning assistant on the histopathologic classification of liver cancer
46. Homocysteine and cognitive function in Parkinson's disease
47. Systems biology approach to late-onset Alzheimer's disease genome-wide association study identifies novel candidate genes validated using brain expression data and Caenorhabditis elegans experiments
48. Transethnic genome-wide scan identifies novel Alzheimer's disease loci
49. Multivariate prediction of dementia in Parkinson’s disease
50. Author Correction: Engineering monocyte/macrophage−specific glucocerebrosidase expression in human hematopoietic stem cells using genome editing
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.